Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7Gastrointestinal 4Tumor-Agnostic 3Dermatologic 2Breast 2Sarcoma 1NET 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Urinary Bladder Neoplasms 13Prostatic Neoplasms 11Kidney Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 3Wilms Tumor 2Carcinoma, Renal Cell 2Urologic Neoplasms 1Urethral Neoplasms 1Testicular Neoplasms 1Teratoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Prostate CA 1Prostate Adenocarcinoma 1Pain, Postoperative 1Pain 1Ovarian Germ Cell Cancer 1Oligometastatic Renal Cell Carcinoma 1Neoplasms, Second Primary 1Neoplasms 1Neoplasm Metastasis 1Muscle Invasive Bladder Cancer 1Lung Neoplasms 1Endodermal Sinus Tumor 1Directly Observed Therapy 1Carcinoma, Transitional Cell 1Adenocarcinoma 1Acute Kidney Injury 1

Interventions

Docetaxel 35pembrolizumab 32Nivolumab 27enzalutamide 20Prednisone 20Sunitinib 16Cyclophosphamide 16aldesleukin 14Zoledronic Acid 13Interleukin-2 13Gemcitabine 13Bevacizumab 13Specimen Handling 12Ipilimumab 12Radiosurgery 11Everolimus 11Androgen Antagonists 11Abiraterone Acetate 11fludarabine 10Sorafenib 10Radiotherapy 10Paclitaxel 10Magnetic Resonance Spectroscopy 10pazopanib 9abiraterone 9Doxorubicin 8Carboplatin 8Biopsy 8avelumab 7temsirolimus 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Surgical Procedures, Operative × Genitourinary × Clear all
NCT01751438 2023-04-27

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

M.D. Anderson Cancer Center

Phase 2 Completed
180 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡